Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company's Business Development and International Advocacy Head Dr Raches Ella on Sunday.
'As of now, as per WHO guidelines and guidelines by other countries, people with negative COVID test report are being allowed,' says Health Ministry Joint Secretary
The Union health ministry said recently that it expects 750 million doses of Covishield to be available between August and December.
India stopped exporting Covid-19 vaccines in mid-April, leaving low-income and lower-middle-income countries in the lurch.
The company said the quick ramp up of additional manufacturing capacities for Covaxin was done at Chiron Behring Vaccines, Ankleshwar Gujarat, a wholly owned subsidiary of Bharat Biotech
'Product availability of additional doses to commence from Q4, 2021 at Chiron Behring Vaccines Ltd, located in Ankleshwar, Gujarat,' Bharat Biotech says
At present, SII sells its vaccine Covishield to the Centre for Rs 150 per dose, to state governments for Rs 300 and to private hospitals for Rs 600.
Maharashtra Deputy Chief Minister Ajit Pawar on Monday dismissed the allegation that he has diverted a Bharat Biotech project of manufacturing Covid-19 vaccines to his home district Pune
Bharat Biotech's Covaxin manufacturing facility that is under construction in Karnataka would have a manufacturing capacity of 40 to 50 million doses a month by August-end, says state Health Minister
Indian firms need to prepare for export boom by vaccinating employees, their family members; and prioritise export market
The company said it has tied up with the Gujarat government to explore the production of Covid-19 vaccine through technology transfer from Bharat Biotech
Vaccine effective against all emerging coronavirus variants, says study
Hester Biosciences on Sunday said it has tied up with the Gujarat government to explore the production of the Covid-19 vaccine through technology transfer from Bharat Biotech
Timelines suggest govt must focus on health infra too
Bharat Biotech said its Covid-19 vaccine 'Covaxin' has been found to be effective against coronavirus strains found in India and the UK
Karnataka will soon have a Covaxin-manufacturing plant of Bharat Biotech in Kolar district near, says Deputy Chief Minister of the State Dr C N Ashwath Narayan
Bharat Biotech on Friday said it has dispatched COVID vaccine Covaxin to various states like Gujarat, Assam, Tamil Nadu, Karnataka and Odisha. The Hyderabad-based vaccine major, which has come under fire from the Delhi government over supply-related issues, said it has also dispatched Covaxin lots to Kerala and Uttarakhand. "Covaxin goes to Gandhinagar, Guwahati, Chennai, Hyderabad, Bengaluru & Bhuvneshwar. thank all our employees @ BHarat bio who worked thru the holy month of Ramzan..." Bharat Biotech Co-Founder and Joint Managing Director Suchitra Ella said in a tweet. Earlier in a late night tweet on Thursday, she tweeted informing supply of the much in demand vaccine to Kerala and Uttarakhand. "Covaxin sent to Kerala & Uttarakhand. Thanq for the concern, many offered to help. Our work is highly stringent, realtime & technical,no work from home! All Our employees will be taken care of, won't deter us from our mission! Let's be thankful,helpful & hopeful always," she
Biovet Pvt Ltd, an associate firm of Bharat Biotech, is confident of making a plant at Manjari in Pune fully functional for vaccine production by August-end, a senior administrative official said
India has vaccinated 37.2 million people with both doses of a vaccine, and about 135.5 million have received at least the first jab
The firm is supplying Covaxin to 18 states, including AP, Haryana, Odisha, Assam, J&K, Tamil Nadu, Bihar, Jharkhand as well as Delhi